NVR vs SLRX · P/E 15, rev $4.21B vs $4.9M cap
NVR Inc (NVR) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
NVR currently screens at market cap $16.94B and trailing P/E 15.3. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the NVR and SLRX stock pages for the full models.
Not investment advice.